|
1
|
Rauh J, Milan F, Günther KP and Stiehler
M: Bioreactor systems for bone tissue engineering. Tissue Eng Part
B, Rev. 17:263–280. 2011. View Article : Google Scholar
|
|
2
|
Loesche WJ and Grossman NS: Periodontal
disease as a specific, albeit chronic, infection: Diagnosis and
treatment. Clin Microbiol Rev. 14:727–752, table of contents. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Orlic D, Kajstura J, Chimenti S, Jakoniuk
I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM,
et al: Bone marrow cells regenerate infarcted myocardium. Nature.
410:701–705. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pittenger MF, Mackay AM, Beck SC, Jaiswal
RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and
Marshak DR: Multilineage potential of adult human mesenchymal stem
cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
In't Anker PS, Scherjon SA, Kleijburg-van
der Keur C, de Groot-Swings GM, Claas FH, Fibbe WE and Kanhai HH:
Isolation of mesenchymal stem cells of fetal or maternal origin
from human placenta. Stem Cells. 22:1338–1345. 2004. View Article : Google Scholar
|
|
6
|
Murphy MB, Moncivais K and Caplan AI:
Mesenchymal stem cells: Environmentally responsive therapeutics for
regenerative medicine. Exp Mol Med. 45:e542013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Aubin JE: Regulation of osteoblast
formation and function. Rev Endoc Metab Disord. 2:81–94. 2001.
View Article : Google Scholar
|
|
8
|
Long F: Building strong bones: Molecular
regulation of the osteoblast lineage. Nat Rev Mol Cell Biol.
13:27–38. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zomorodian E and Baghaban Eslaminejad M:
Mesenchymal stem cells as a potent cell source for bone
regeneration. Stem Cells Int. 2012:9803532012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jones E and Yang X: Mesenchymal stem cells
and bone regeneration: Current status. Injury. 42:562–568. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xiao Y, Mareddy S and Crawford R: Clonal
characterization of bone marrow derived stem cells and their
application for bone regeneration. Int J Oral Sci. 2:127–135.
2010.PubMed/NCBI
|
|
12
|
Motterlini R, Gonzales A, Foresti R, Clark
JE, Green CJ and Winslow RM: Heme oxygenase-1-derived carbon
monoxide contributes to the suppression of acute hypertensive
responses in vivo. Circ Res. 83:568–577. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sammut IA, Foresti R, Clark JE, Exon DJ,
Vesely MJ, Sarathchandra P, Green CJ and Motterlini R: Carbon
monoxide is a major contributor to the regulation of vascular tone
in aortas expressing high levels of haeme oxygenase-1. Br J
Pharmacol. 125:1437–1444. 1998. View Article : Google Scholar
|
|
14
|
Zhang X, Shan P, Otterbein LE, Alam J,
Flavell RA, Davis RJ, Choi AM and Lee PJ: Carbon monoxide
inhibition of apoptosis during ischemia-reperfusion lung injury is
dependent on the p38 mitogen-activated protein kinase pathway and
involves caspase 3. J Biol Chem. 278:1248–1258. 2003. View Article : Google Scholar
|
|
15
|
Otterbein LE, Bach FH, Alam J, Soares M,
Tao Lu H, Wysk M, Davis RJ, Flavell RA and Choi AM: Carbon monoxide
has anti-inflammatory effects involving the mitogen-activated
protein kinase pathway. Nat Med. 6:422–428. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Matsumoto M, Makino Y, Tanaka T, Tanaka H,
Ishizaka N, Noiri E, Fujita T and Nangaku M: Induction of
renoprotective gene expression by cobalt ameliorates ischemic
injury of the kidney in rats. J Am Soc Nephrol. 14:1825–1832. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sikorski EM, Hock T, Hill-Kapturczak N and
Agarwal A: The story so far: Molecular regulation of the heme
oxygenase-1 gene in renal injury. Am J Physiol Renal Physiol.
286:F425–F441. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Motterlini R, Mann BE, Johnson TR, Clark
JE, Foresti R and Green CJ: Bioactivity and pharmacological actions
of carbon monoxide-releasing molecules. Curr Pharm Des.
9:2525–2539. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Foresti R, Hammad J, Clark JE, Johnson TR,
Mann BE, Friebe A, Green CJ and Motterlini R: Vasoactive properties
of CORM-3, a novel water-soluble carbon monoxide-releasing
molecule. Br J Pharmacol. 142:453–460. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jiang L, Fei D, Gong R, Yang W, Yu W, Pan
S and Zhao M and Zhao M: CORM-2 inhibits TXNIP/NLRP3 inflammasome
pathway in LPS-induced acute lung injury. Inflamm Res. 65:905–915.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods.
25:402–408. 2001. View Article : Google Scholar
|
|
22
|
Seo BM, Miura M, Gronthos S, Bartold PM,
Batouli S, Brahim J, Young M, Robey PG, Wang CY and Shi S:
Investigation of multipotent postnatal stem cells from human
periodontal ligament. Lancet. 364:149–155. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tsai TL and Li WJ: Identification of bone
marrow-derived soluble factors regulating human mesenchymal stem
cells for bone regeneration. Stem cell Rep. 8:387–400. 2017.
View Article : Google Scholar
|
|
24
|
Vahabi S, Torshabi M and Mohammadi M:
Osteoinductive activity of DFDBA materials versus growth factors on
gene expression of MG-63 cells: An in vitro study. J Long Term Eff
Med Implants. 26:133–142. 2016. View Article : Google Scholar
|
|
25
|
Gothard D, Smith EL, Kanczler JM, Rashidi
H, Qutachi O, Henstock J, Rotherham M, El Haj A, Shakesheff KM and
Oreffo RO: Tissue engineered bone using select growth factors: A
comprehensive review of animal studies and clinical translation
studies in man. Eur Cells Mater. 28:166–208. 2014. View Article : Google Scholar
|
|
26
|
Bessa PC, Casal M and Reis RL: Bone
morphogenetic proteins in tissue engineering: The road from the
laboratory to the clinic, part I (basic concepts). J Tissue Eng
Regen Med. 2:1–13. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bessa PC, Casal M and Reis RL: Bone
morphogenetic proteins in tissue engineering: The road from
laboratory to clinic, part II (BMP delivery). J of Tissue Eng Regen
Med. 2:81–96. 2008. View
Article : Google Scholar
|
|
28
|
Fu R, Selph S, McDonagh M, Peterson K,
Tiwari A, Chou R and Helfand M: Effectiveness and harms of
recombinant human bone morphogenetic protein-2 in spine fusion: A
systematic review and meta-analysis. Ann Intern Med. 158:890–902.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mesfin A, Buchowski JM, Zebala LP, Bakhsh
WR, Aronson AB, Fogelson JL, Hershman S, Kim HJ, Ahmad A and
Bridwell KH: High-dose rhBMP-2 for adults: Major and minor
complications: A study of 502 spine cases. J Bone Joint Surg Am.
95:1546–1553. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao HQ, Hou M, Wei LL, Mu P, Song H and
Yang P: Mechanism of carbon monoxide affecting the expression of
cellular adhesion molecule under stimulation of inflammatory
cytokines to human gingival fibroblasts. Hua Xi Kou Qiang Yi Xue Za
Zhi. 31:420–424. 2013.(In Chinese).PubMed/NCBI
|
|
31
|
Wei L, Hou M, Wang P and Song H: Effect of
carbon monoxide releasing molecule on experimental periodontitis in
rats. Hua Xi Kou Qiang Yi Xue Za Zhi. 32:23–26. 2014.(In
Chinese).PubMed/NCBI
|
|
32
|
Deng Y, Wu S, Zhou H, Bi X, Wang Y, Hu Y,
Gu P and Fan X: Effects of a miR-31, Runx2, and Satb2 regulatory
loop on the osteogenic differentiation of bone mesenchymal stem
cells. Stem Cells Dev. 22:2278–2286. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schroeder TM, Jensen ED and Westendorf JJ:
Runx2: A master organizer of gene transcription in developing and
maturing osteoblasts. Birth Defects Res C Embryo Today. 75:213–215.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Komori T, Yagi H, Nomura S, Yamaguchi A,
Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, et al:
Targeted disruption of Cbfa1 results in a complete lack of bone
formation owing to maturational arrest of osteoblasts. Cell.
89:755–764. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ching HS, Luddin N, Rahman IA and Ponnuraj
KT: Expression of odontogenic and osteogenic markers in DPSCs and
SHED: A review. Curr Stem Cell Res Ther. 12:71–79. 2017. View Article : Google Scholar
|
|
36
|
Terkeltaub RA: Inorganic pyrophosphate
generation and disposition in pathophysiology. Am J Physiol Cell
Physiol. 281:C1–C11. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wennberg C, Hessle L, Lundberg P, Mauro S,
Narisawa S, Lerner UH and Millán JL: Functional characterization of
osteoblasts and osteoclasts from alkaline phosphatase knockout
mice. J Bone Miner Res. 15:1879–1888. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Vanella L, Kim DH, Asprinio D, Peterson
SJ, Barbagallo I, Vanella A, Goldstein D, Ikehara S, Kappas A and
Abraham NG: HO-1 expression increases mesenchymal stem cell-derived
osteoblasts but decreases adipocyte lineage. Bone. 46:236–243.
2010. View Article : Google Scholar
|
|
39
|
Barbagallo I, Vanella A, Peterson SJ, Kim
DH, Tibullo D, Giallongo C, Vanella L, Parrinello N, Palumbo GA, Di
Raimondo F, et al: Overexpression of heme oxygenase-1 increases
human osteoblast stem cell differentiation. J Bone Miner Metab.
28:276–288. 2010. View Article : Google Scholar
|
|
40
|
Bathoorn E, Slebos DJ, Postma DS, Koeter
GH, van Oosterhout AJ, van der Toorn M, Boezen HM and Kerstjens HA:
Anti-inflammatory effects of inhaled carbon monoxide in patients
with COPD: A pilot study. Eur Respir J. 30:1131–1137. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Levitt DG and Levitt MD: Carbon monoxide:
A critical quantitative analysis and review of the extent and
limitations of its second messenger function. Clin Pharmacol.
7:37–56. 2015.PubMed/NCBI
|
|
42
|
Otterbein LE, Foresti R and Motterlini R:
Heme oxygenase-1 and carbon monoxide in the heart: The balancing
act between danger signaling and pro-survival. Circ Res.
118:1940–1959. 2016. View Article : Google Scholar : PubMed/NCBI
|
